Non-small Cell Lung Cancer with Rearranged Alk Gene Fusion Protein or Kras Mutation
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer with Rearranged Alk Gene Fusion Protein or Kras Mutation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) [Phase 1]
Phase 1 dose-finding study of birabresib (MK-8628), a BET inhibitor, completed with results posted in 2018 for selected advanced solid tumor…